Scopio Labs today announced the publication of a new study that examines the impact of implementing remote* digital microscopy for peripheral blood smear (PBS) analysis.
| Study at Tel Aviv Sourasky Medical Center is first to quantify tele-hematology’s impact on laboratory performance; demonstrates more efficient workflows and decrease in costs TEL AVIV, Israel, April 27, 2023 /PRNewswire/ -- Scopio Labs today announced the publication of a new study that examines the impact of implementing remote* digital microscopy for peripheral blood smear (PBS) analysis. Conducted by Tel Aviv Sourasky Medical Center (TASMC) and published in Applied Clinical Informatics, the study found that the application of Scopio’s digital imaging and analysis system significantly reduces laboratory turnaround time (TAT) for PBS review, as compared to TASMC’s previous digital morphology workflow. Most hospital-attached clinical laboratories suffer from delayed turnaround time (TAT) – a major benchmark for laboratory performance, including for peripheral blood smears. Hematology labs are facing pressure to work more efficiently, but existing digital morphology analyzers have a limited field of view and may require qualified experts to make return trips to the microscope. The study measured the impact of altering the weekend lab workflow using fully remote digital microscopy via Scopio’s X100 with Full-Field PBS Application, looking specifically at workflow efficiency and turnaround time. A total of 10,704 PBS samples were reviewed during two five-month periods. “Scopio’s platform significantly reduced turnaround times and improved efficiency of the hematology lab’s morphology analysis,” said Dr. Ben-Zion Katz, Ph.D., lead author of the study. “By adding remote PBS review capacity over the weekends, we were able to decrease weekend turnaround times for PBS review and eliminate a huge backlog at the start of the week, all without requiring additional staff in the lab on the weekend. We saw clinical benefits, achieved net cost savings, and provided flexibility to our skilled staff.” Key findings from the study include the following:
Prior to this study, Scopio’s suite of digital imaging and analysis platforms had already increased efficiency for Tel Aviv Sourasky Medical Center’s hematology laboratory. This study is the first to quantify an increase in terms of PBS turnaround time (TAT), staff hours, and costs. “For TASMC, being able to achieve timely detection from different physical locations is a game-changer,” said Itai Hayut, CEO and Co-Founder of Scopio Labs. “Improving turnaround time better equips hematology labs to fulfill their crucial role in saving lives. We are encouraged by this study’s promising results.” *Remote review is accessible only for authorized users via the hospital’s secure network. About Scopio Scopio Labs’ suite of digital imaging and analysis platforms supports laboratory experts with timely detection of blood-related medical conditions, expediting patients’ access to life-saving treatments. Scopio solves the age-old tradeoff between resolution and field of view, enabling unprecedented scale and depth in cell morphology. High-resolution imaging and embedded AI combine for more efficient workflow, contributing to better diagnostics across the continuum of care. Scopio Labs’ Full-Field Peripheral Blood Smear™ Application is FDA-cleared and CE-marked for use with the Scopio X100 and Scopio X100HT high-resolution scanners. The Full-Field Bone Marrow Aspirate™ Application is CE-marked for use with both devices. To learn more, visit scopiolabs.com. Media Contact: Josh Warhit
SOURCE Scopio Labs |
View original content:
